Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
ernesto.maddaloni@uniroma1.it
Ernesto Maddaloni
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
ernesto.maddaloni@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2025
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes
DIABETES RESEARCH AND CLINICAL PRACTICE
2025
AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes
DIABETES THERAPY
2025
Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes
CARDIOVASCULAR DIABETOLOGY
2025
Searching the Crystal Ball for Tailored GLP‐1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity
DIABETES/METABOLISM RESEARCH AND REVIEWS
2025
Osteocalcin is inversely associated with worse adipose tissue distribution and cardiovascular risk in autoimmune diabetes
DIABETES RESEARCH AND CLINICAL PRACTICE
2025
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study)
DIABETES THERAPY
2025
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis
DIABETES RESEARCH AND CLINICAL PRACTICE
2025
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study
DIABETES, OBESITY AND METABOLISM
2024
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
EXPERT OPINION ON INVESTIGATIONAL DRUGS
2024
Obesity in type 1 diabetes: an overlooked immune-metabolic issue
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM
2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study
CLINICAL THERAPEUTICS
2024
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes
DIABETES/METABOLISM RESEARCH AND REVIEWS
2024
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2024
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)
THE LANCET DIABETES & ENDOCRINOLOGY
2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes
DIABETES/METABOLISM RESEARCH AND REVIEWS
2023
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials
DIABETES, OBESITY AND METABOLISM
2023
Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia
JOURNAL OF CLINICAL MEDICINE
2023
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy
JOURNAL OF CLINICAL MEDICINE
2023
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
1
2
3
4
5
6
seguente ›
ultima »
Progetti di Ricerca
Correlazione tra Fragilità Ossea e Neuropatia Autonomica nel Diabete Autoimmune
Gruppi di ricerca
Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma